[email protected]

Home
About Us
- Helios Objectives
- Helios Governance
  - Core group
  - Management Committee
News & Events
- Events
- News
- Blog
Grant Opportunities
Resources
- Newsletter
- HELIOS REDcap
Join Us
Contact Us

Home
About Us
- Helios Objectives
- Helios Governance
  - Core group
  - Management Committee
News & Events
- Events
- News
- Blog
Grant Opportunities
Resources
- Newsletter
- HELIOS REDcap
Join Us
Contact Us

JOIN OUR WEBINARS

NHS Approves Revolutionary CRISPR Gene Therapy for Sickle Cell Disease

February 5, 2025 No Comments

HELIOS at ASCAT Conference 2024: Advancing Hemoglobinopathy Research Through Collaboration

November 18, 2024 No Comments

February 15, 2024

HELIOS website goes live!

WG5 – Dissemination and outreach has just published the HELIOS website that you can visit here!

PrevPreviousHELIOS Survey on molecular research

NextOur first Short-Term Scientific Mission on standardizing annotation of structural hemoglobinopathies!Next

Subscribe to our newsletter to keep you up to date on our activities.

I agree to receive the newsletter and know that I can easily unsubscribe at any time.

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. COST Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
www.cost.eu

Features

Home
Privacy Policy

Home
Privacy Policy

Contact Us

[email protected]

Facebook Instagram Linkedin Twitter Youtube

Related articles